nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Neuropathy—Metformin—metabolic syndrome X	0.0347	0.0441	CcSEcCtD
Alfuzosin—Injury—Metformin—metabolic syndrome X	0.0292	0.0371	CcSEcCtD
Alfuzosin—Abdominal pain upper—Metformin—metabolic syndrome X	0.0245	0.0311	CcSEcCtD
Alfuzosin—Breast disorder—Metformin—metabolic syndrome X	0.0243	0.0308	CcSEcCtD
Alfuzosin—Angina pectoris—Metformin—metabolic syndrome X	0.0226	0.0287	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0216	0.0274	CcSEcCtD
Alfuzosin—Infestation—Metformin—metabolic syndrome X	0.0207	0.0263	CcSEcCtD
Alfuzosin—Infestation NOS—Metformin—metabolic syndrome X	0.0207	0.0263	CcSEcCtD
Alfuzosin—Drowsiness—Metformin—metabolic syndrome X	0.0207	0.0263	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Metformin—metabolic syndrome X	0.0203	0.0258	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Metformin—metabolic syndrome X	0.0196	0.0249	CcSEcCtD
Alfuzosin—Rhinitis—Metformin—metabolic syndrome X	0.0186	0.0236	CcSEcCtD
Alfuzosin—Connective tissue disorder—Metformin—metabolic syndrome X	0.0183	0.0232	CcSEcCtD
Alfuzosin—Eye disorder—Metformin—metabolic syndrome X	0.0174	0.022	CcSEcCtD
Alfuzosin—Flushing—Metformin—metabolic syndrome X	0.0172	0.0219	CcSEcCtD
Alfuzosin—Cardiac disorder—Metformin—metabolic syndrome X	0.0172	0.0219	CcSEcCtD
Alfuzosin—Angiopathy—Metformin—metabolic syndrome X	0.0169	0.0214	CcSEcCtD
Alfuzosin—Mediastinal disorder—Metformin—metabolic syndrome X	0.0167	0.0213	CcSEcCtD
Alfuzosin—Ill-defined disorder—Metformin—metabolic syndrome X	0.015	0.0191	CcSEcCtD
Alfuzosin—Malaise—Metformin—metabolic syndrome X	0.0146	0.0185	CcSEcCtD
Alfuzosin—Syncope—Metformin—metabolic syndrome X	0.0145	0.0184	CcSEcCtD
Alfuzosin—Palpitations—Metformin—metabolic syndrome X	0.0143	0.0181	CcSEcCtD
Alfuzosin—Loss of consciousness—Metformin—metabolic syndrome X	0.0142	0.018	CcSEcCtD
Alfuzosin—Chest pain—Metformin—metabolic syndrome X	0.0138	0.0175	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0137	0.0174	CcSEcCtD
Alfuzosin—Discomfort—Metformin—metabolic syndrome X	0.0136	0.0173	CcSEcCtD
Alfuzosin—Oedema—Metformin—metabolic syndrome X	0.0132	0.0168	CcSEcCtD
Alfuzosin—Infection—Metformin—metabolic syndrome X	0.0131	0.0166	CcSEcCtD
Alfuzosin—Shock—Metformin—metabolic syndrome X	0.013	0.0165	CcSEcCtD
Alfuzosin—Nervous system disorder—Metformin—metabolic syndrome X	0.0129	0.0164	CcSEcCtD
Alfuzosin—Thrombocytopenia—Metformin—metabolic syndrome X	0.0129	0.0164	CcSEcCtD
Alfuzosin—Skin disorder—Metformin—metabolic syndrome X	0.0128	0.0163	CcSEcCtD
Alfuzosin—Hyperhidrosis—Metformin—metabolic syndrome X	0.0128	0.0162	CcSEcCtD
Alfuzosin—Hypotension—Metformin—metabolic syndrome X	0.0123	0.0157	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.012	0.0153	CcSEcCtD
Alfuzosin—Somnolence—Metformin—metabolic syndrome X	0.0117	0.0149	CcSEcCtD
Alfuzosin—Dyspepsia—Metformin—metabolic syndrome X	0.0116	0.0148	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.0114	0.0145	CcSEcCtD
Alfuzosin—Fatigue—Metformin—metabolic syndrome X	0.0114	0.0144	CcSEcCtD
Alfuzosin—Constipation—Metformin—metabolic syndrome X	0.0113	0.0143	CcSEcCtD
Alfuzosin—Feeling abnormal—Metformin—metabolic syndrome X	0.0109	0.0138	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Metformin—metabolic syndrome X	0.0108	0.0137	CcSEcCtD
Alfuzosin—Urticaria—Metformin—metabolic syndrome X	0.0105	0.0133	CcSEcCtD
Alfuzosin—Abdominal pain—Metformin—metabolic syndrome X	0.0104	0.0132	CcSEcCtD
Alfuzosin—Asthenia—Metformin—metabolic syndrome X	0.00947	0.012	CcSEcCtD
Alfuzosin—Pruritus—Metformin—metabolic syndrome X	0.00934	0.0119	CcSEcCtD
Alfuzosin—Diarrhoea—Metformin—metabolic syndrome X	0.00903	0.0115	CcSEcCtD
Alfuzosin—Dizziness—Metformin—metabolic syndrome X	0.00873	0.0111	CcSEcCtD
Alfuzosin—Vomiting—Metformin—metabolic syndrome X	0.00839	0.0107	CcSEcCtD
Alfuzosin—Rash—Metformin—metabolic syndrome X	0.00833	0.0106	CcSEcCtD
Alfuzosin—Dermatitis—Metformin—metabolic syndrome X	0.00832	0.0106	CcSEcCtD
Alfuzosin—Headache—Metformin—metabolic syndrome X	0.00827	0.0105	CcSEcCtD
Alfuzosin—Nausea—Metformin—metabolic syndrome X	0.00784	0.00995	CcSEcCtD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.00119	0.0056	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—HTR2C—metabolic syndrome X	0.00116	0.00548	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.00115	0.00544	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—GHRL—metabolic syndrome X	0.0011	0.00519	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.00108	0.0051	CbGpPWpGaD
Alfuzosin—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.00107	0.00503	CbGpPWpGaD
Alfuzosin—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00105	0.00496	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—metabolic syndrome X	0.00104	0.0049	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—HTR2C—metabolic syndrome X	0.00103	0.00487	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.00102	0.00483	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.000988	0.00466	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.000985	0.00464	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—GHRL—metabolic syndrome X	0.000978	0.00461	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.000972	0.00458	CbGpPWpGaD
Alfuzosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00096	0.00453	CbGpPWpGaD
Alfuzosin—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000938	0.00442	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000927	0.00437	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—metabolic syndrome X	0.000923	0.00435	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000906	0.00427	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.000898	0.00423	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000879	0.00414	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.000877	0.00414	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.000875	0.00413	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.000832	0.00392	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—AGT—metabolic syndrome X	0.000815	0.00384	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.000806	0.0038	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.000798	0.00376	CbGpPWpGaD
Alfuzosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000794	0.00374	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00077	0.00363	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000752	0.00355	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00073	0.00344	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.000729	0.00344	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.000716	0.00338	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000706	0.00333	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.000691	0.00326	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000684	0.00322	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—AGT—metabolic syndrome X	0.000676	0.00319	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—GHRL—metabolic syndrome X	0.000669	0.00316	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000668	0.00315	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000648	0.00305	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000645	0.00304	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CNR1—metabolic syndrome X	0.000634	0.00299	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.000614	0.00289	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.000605	0.00285	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—AGT—metabolic syndrome X	0.000601	0.00283	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.000593	0.0028	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000586	0.00276	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—GHRL—metabolic syndrome X	0.000556	0.00262	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00054	0.00254	CbGpPWpGaD
Alfuzosin—ADRA1B—LPA receptor mediated events—AKT1—metabolic syndrome X	0.000538	0.00254	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.000537	0.00253	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000535	0.00252	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CNR1—metabolic syndrome X	0.000526	0.00248	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000521	0.00245	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000512	0.00241	CbGpPWpGaD
Alfuzosin—ADRA1B—AMPK Signaling—AKT1—metabolic syndrome X	0.000507	0.00239	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—GHRL—metabolic syndrome X	0.000493	0.00233	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CCL5—metabolic syndrome X	0.000491	0.00232	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000479	0.00226	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000476	0.00224	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CNR1—metabolic syndrome X	0.000467	0.0022	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000465	0.00219	CbGpPWpGaD
Alfuzosin—ADRA1A—AMPK Signaling—AKT1—metabolic syndrome X	0.00045	0.00212	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000448	0.00211	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000444	0.0021	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000425	0.002	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—AGT—metabolic syndrome X	0.000411	0.00194	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CCL5—metabolic syndrome X	0.000408	0.00192	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000399	0.00188	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000398	0.00188	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000386	0.00182	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000378	0.00178	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000378	0.00178	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000369	0.00174	CbGpPWpGaD
Alfuzosin—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000367	0.00173	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000362	0.00171	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CCL5—metabolic syndrome X	0.000362	0.00171	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000358	0.00169	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—GHRL—metabolic syndrome X	0.000344	0.00162	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000343	0.00162	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—AGT—metabolic syndrome X	0.000341	0.00161	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CCL2—metabolic syndrome X	0.000338	0.0016	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000331	0.00156	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000328	0.00154	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CNR1—metabolic syndrome X	0.000325	0.00153	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000314	0.00148	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HDAC3—metabolic syndrome X	0.000307	0.00145	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—AGT—metabolic syndrome X	0.000303	0.00143	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000301	0.00142	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000297	0.0014	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000294	0.00139	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—GHRL—metabolic syndrome X	0.000285	0.00134	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CCL2—metabolic syndrome X	0.000281	0.00132	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000279	0.00131	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000278	0.00131	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000275	0.0013	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CNR1—metabolic syndrome X	0.00027	0.00127	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TRIB3—metabolic syndrome X	0.000268	0.00126	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RBP4—metabolic syndrome X	0.000268	0.00126	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000267	0.00126	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000267	0.00126	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000264	0.00124	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HDAC3—metabolic syndrome X	0.000255	0.0012	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—GHRL—metabolic syndrome X	0.000253	0.00119	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CCL5—metabolic syndrome X	0.000252	0.00119	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000251	0.00118	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CCL2—metabolic syndrome X	0.00025	0.00118	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CNR1—metabolic syndrome X	0.00024	0.00113	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOC3—metabolic syndrome X	0.000237	0.00112	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AGT—metabolic syndrome X	0.000232	0.00109	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00023	0.00109	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000228	0.00108	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000227	0.00107	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TRIB3—metabolic syndrome X	0.000222	0.00105	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RBP4—metabolic syndrome X	0.000222	0.00105	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000221	0.00104	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR2C—metabolic syndrome X	0.000214	0.00101	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AGT—metabolic syndrome X	0.000211	0.000994	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCL5—metabolic syndrome X	0.000209	0.000986	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000208	0.000983	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CYBA—metabolic syndrome X	0.000207	0.000977	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000205	0.000965	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GHRL—metabolic syndrome X	0.000203	0.000957	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000203	0.000955	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000197	0.000931	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RBP4—metabolic syndrome X	0.000197	0.000931	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOC3—metabolic syndrome X	0.000197	0.000928	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000197	0.000926	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AGT—metabolic syndrome X	0.000193	0.000909	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CNR1—metabolic syndrome X	0.000192	0.000906	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000186	0.000876	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000185	0.000873	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000183	0.000861	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000178	0.000837	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AGT—metabolic syndrome X	0.000175	0.000825	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOC3—metabolic syndrome X	0.000175	0.000824	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CCL2—metabolic syndrome X	0.000174	0.000819	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CYBA—metabolic syndrome X	0.000172	0.000811	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000171	0.000807	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GHRL—metabolic syndrome X	0.000168	0.000794	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000163	0.000767	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000163	0.000767	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CNR1—metabolic syndrome X	0.000159	0.000752	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000158	0.000744	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF2—metabolic syndrome X	0.000157	0.000741	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AGT—metabolic syndrome X	0.000155	0.000733	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000153	0.000721	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CYBA—metabolic syndrome X	0.000153	0.00072	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOB—metabolic syndrome X	0.000153	0.000719	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GHRL—metabolic syndrome X	0.00015	0.000705	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL5—metabolic syndrome X	0.000149	0.000702	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000148	0.000699	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LPL—metabolic syndrome X	0.000146	0.000687	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000144	0.00068	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CNR1—metabolic syndrome X	0.000142	0.000668	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF2—metabolic syndrome X	0.00013	0.000615	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.00013	0.000613	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000128	0.000604	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOB—metabolic syndrome X	0.000127	0.000597	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AGT—metabolic syndrome X	0.000125	0.000587	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL5—metabolic syndrome X	0.000124	0.000583	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	0.000123	0.000581	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000123	0.000581	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LEP—metabolic syndrome X	0.000122	0.000575	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOE—metabolic syndrome X	0.000122	0.000575	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LPL—metabolic syndrome X	0.000121	0.00057	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOA1—metabolic syndrome X	0.000121	0.000569	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF2—metabolic syndrome X	0.000116	0.000546	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	0.000112	0.00053	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—G6PD—metabolic syndrome X	0.00011	0.000518	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	0.00011	0.000518	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000109	0.000516	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IRS1—metabolic syndrome X	0.000109	0.000513	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	0.000107	0.000506	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	0.000107	0.000506	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GCKR—metabolic syndrome X	0.000105	0.000494	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPA—metabolic syndrome X	0.000105	0.000494	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—INS—metabolic syndrome X	0.000104	0.000492	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AGT—metabolic syndrome X	0.000103	0.000487	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL2—metabolic syndrome X	0.000103	0.000484	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	0.000102	0.000479	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LEP—metabolic syndrome X	0.000101	0.000478	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOE—metabolic syndrome X	0.000101	0.000478	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF1—metabolic syndrome X	0.000101	0.000476	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA5—metabolic syndrome X	0.000101	0.000474	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	0.0001	0.000472	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SERPINE1—metabolic syndrome X	9.58e-05	0.000452	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	9.34e-05	0.000441	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	9.19e-05	0.000433	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	9.15e-05	0.000431	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	9.04e-05	0.000426	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	9e-05	0.000424	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	9e-05	0.000424	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	8.9e-05	0.000419	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	8.66e-05	0.000408	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	8.52e-05	0.000401	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	8.38e-05	0.000395	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	8.37e-05	0.000395	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LIPC—metabolic syndrome X	8.33e-05	0.000393	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GCK—metabolic syndrome X	8.33e-05	0.000393	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOC3—metabolic syndrome X	8.28e-05	0.00039	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CETP—metabolic syndrome X	8.04e-05	0.000379	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	8.03e-05	0.000378	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	7.95e-05	0.000375	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	7.84e-05	0.000369	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	7.71e-05	0.000364	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	7.7e-05	0.000363	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	7.69e-05	0.000362	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	7.59e-05	0.000358	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	7.56e-05	0.000357	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	7.47e-05	0.000352	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	7.44e-05	0.000351	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GOT2—metabolic syndrome X	7.27e-05	0.000343	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	7.27e-05	0.000343	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	7.12e-05	0.000335	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.06e-05	0.000333	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	6.74e-05	0.000318	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	6.5e-05	0.000307	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	6.48e-05	0.000305	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	6.48e-05	0.000305	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	6.4e-05	0.000302	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GGT1—metabolic syndrome X	6.27e-05	0.000296	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GOT1—metabolic syndrome X	6.27e-05	0.000296	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	6.05e-05	0.000285	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	5.91e-05	0.000278	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.78e-05	0.000272	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	5.69e-05	0.000268	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOB—metabolic syndrome X	5.32e-05	0.000251	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	5.25e-05	0.000247	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	5.18e-05	0.000244	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPL—metabolic syndrome X	5.08e-05	0.00024	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	5.02e-05	0.000237	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CD36—metabolic syndrome X	4.83e-05	0.000228	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	4.56e-05	0.000215	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARA—metabolic syndrome X	4.49e-05	0.000212	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	4.46e-05	0.00021	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AGT—metabolic syndrome X	4.35e-05	0.000205	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOE—metabolic syndrome X	4.26e-05	0.000201	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA1—metabolic syndrome X	4.21e-05	0.000199	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	4.2e-05	0.000198	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	3.78e-05	0.000178	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—metabolic syndrome X	3.71e-05	0.000175	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—INS—metabolic syndrome X	3.64e-05	0.000172	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	3.49e-05	0.000164	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	3.36e-05	0.000158	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.34e-05	0.000157	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.19e-05	0.00015	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.1e-05	0.000146	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.92e-05	0.000138	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.47e-05	6.92e-05	CbGpPWpGaD
